Home › Funds › Trails Edge Capital Partners, LP › IPSC
Trails Edge Capital Partners, LP position in IPSC
CENTURY THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 4,134,969 shares of IPSC (CENTURY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$10.1M, representing 1.61% of its reported portfolio and ranking #25 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IPSC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's IPSC position evolved
Trails Edge Capital Partners, LP first disclosed a stake in IPSC in Q1 2026 at 2,449,993 shares (US$5.5M). The position peaked in Q2 2026 at 4,134,969 shares, worth US$10.1M. Across 2 filings, Trails Edge Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,134,969 shares valued at US$10.1M — an increase of 1,684,976 shares quarter over quarter.. Notable position changes include a 69% increase in Q2 2026 (shares fell 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.45M | $5.54M | New |
| Q2 2026 | 4.13M | $10.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (CENTURY THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Versant Venture Management, LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Versant Venture Management, LLC 12.17M sh · $29.81M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M sh · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Spruce Street Capital LP 4.06M sh · $9.94M · Q2 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held IPSC?
Trails Edge Capital Partners, LP has disclosed IPSC holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Trails Edge Capital Partners, LP's current position in IPSC?
As of Q2 2026, Trails Edge Capital Partners, LP holds 4.13M shares of IPSC (CENTURY THERAPEUTICS INC), valued at $10.13M, representing 1.61% of its reported portfolio and ranking #25.
Has Trails Edge Capital Partners, LP been buying or selling IPSC?
In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP increased its position in IPSC. The position peaked in Q2 2026 at 4.13M shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Versant Venture Management, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.